Kinsenoside is a glycoside with antihyperlipidemic, immunosuppressive, and anti-inflammatory properties. It raises lipolysis mediated by adipose triglyceride lipase and increases hydrolysis of triglycerides in C3H10T1/2 adipocytes. References: Hsiao HB, Lin H, Wu JB, Lin WC. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways. Osteoporos Int. 2013 May;24(5):1663-76. doi: 10.1007/s00198-012-2199-z. Epub 2012 Nov 10. PubMed PMID: 23143538; PubMed Central PMCID: PMC3627854.

纯度：≥98%

CAS：151870-74-5